StockData
Nektar Therapeutics logo

Nektar Therapeutics (NKTR) stock

NKTRNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q4 năm tài chính 2025, quý kết thúc ngày Dec 31, 2025Last filing: 10-Q on Nov 13, 2026Score 9/30
$34.42−1.49 (-4.15%)

Close on Nov 18, 2026Market cap $1.18BP/E –Yield –

Nektar Therapeutics pe ratio

The price-to-earnings ratio is the share price divided by diluted earnings per share over the trailing twelve months.

Nektar Therapeutics's pe ratio was 8.1× on Jul 31, 2019, against 395.7× a year earlier.

PE Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2019Jul 31, 20198.1×−0.2
2018Dec 31, 20188.3×−387.4
2015Oct 30, 2015395.7×–

More Nektar Therapeutics figures

See a number that looks wrong?